14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
The UK government passed reforms on 21 July 2020 lowering the thresholds to intervene in mergers and...
Read More >
Key Points- The law prohibits employers from including unilateral non-disclosure or non-disparageme...
Read More >
Last month New York Governor Cuomo approved amendments to the state’s election laws that provide em...
Read More >
The first year of Governor Gavin Newsom’s term produced many significant pieces of employment legis...
Read More >
Rhode Island is the latest state to jump on the bandwagon of limiting the application of non-compete...
Read More >
Recently, Governor Andrew Cuomo signed two significant bills expanding the scope of anti-discriminat...
Read More >